174 related articles for article (PubMed ID: 16273008)
1. [Has survival of non-small-cell lung cancer patients been ameliorated over the course of the past 20 years?].
Milleron B
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S31-5. PubMed ID: 16273008
[No Abstract] [Full Text] [Related]
2. Invited commentary.
Fieguth HG
Ann Thorac Surg; 2005 Sep; 80(3):1026-7. PubMed ID: 16122478
[No Abstract] [Full Text] [Related]
3. Refining prognosis in non-small-cell lung cancer.
Singh T; Dhindsa J
N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225287
[No Abstract] [Full Text] [Related]
4. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
Van Schil PE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
[No Abstract] [Full Text] [Related]
5. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer treatment present and future.
Cho JK
Hawaii Med J; 2003 Mar; 62(3):61-2. PubMed ID: 12703177
[No Abstract] [Full Text] [Related]
7. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
8. Invited commentary.
Falcoz PE
Ann Thorac Surg; 2008 Jul; 86(1):233-4. PubMed ID: 18573429
[No Abstract] [Full Text] [Related]
9. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
10. New TNM classification for non-small-cell lung cancer.
Tanoue LT; Detterbeck FC
Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
[TBL] [Abstract][Full Text] [Related]
11. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
van Meerbeeck JP; Surmont VF
Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
[TBL] [Abstract][Full Text] [Related]
12. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
[TBL] [Abstract][Full Text] [Related]
13. NCCN: Non-small cell lung cancer.
Ettinger DS; Kris MG;
Cancer Control; 2001; 8(6 Suppl 2):22-31. PubMed ID: 11760555
[No Abstract] [Full Text] [Related]
14. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy for stage I non-small-cell lung cancer--the triumph of technology over biology?
Ball D; Withers HR
Nat Clin Pract Oncol; 2007 Nov; 4(11):614-5. PubMed ID: 17848932
[No Abstract] [Full Text] [Related]
16. Effect of age on survival of clinical stage I non-small-cell lung cancer.
Sigel K; Bonomi M; Packer S; Wisnivesky J
Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
[TBL] [Abstract][Full Text] [Related]
17. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
18. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
19. Pleural effusion in patients with non-small cell carcinoma--stage IV and not T4.
Alon BN; Anson BL
Lung Cancer; 2007 Jul; 57(1):123. PubMed ID: 17445946
[No Abstract] [Full Text] [Related]
20. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
